In the October 11th, 2021 edition of Contemporary OB/GYN, authors (Lo, Hanna & Hedges) offer guidance to medical providers working with women who use marijuana and specific concerns for those patients that are perinatal or prenatal. The authors cite concerns over the increased levels of THC potency in recent years. Specifically, the lack of understanding […]
Pain is the leading reason cited why people use medical marijuana in the United States. Marijuana with low potency levels of tetrahydrocannabinol (THC), i.e. under 5-10%, has shown some efficacy in pain management. However, that’s in stark contrast to the advertised high THC potency levels of marijuana products sold both in medical & recreational dispensaries. […]
A study funded by the National Institute on Drug Abuse (NIDA), “The Associations between prenatal cannabis use disorder and neonatal outcomes” (Y. Shi et.al) examines potential health issues of newborns of mothers with a cannabis use disorder (CUD) at the time of delivery. Researchers reviewed over 4.8 million California birth records from 2001 – 2012. […]
The United States Senate Caucus recently issued a report titled, “Cannabis Policy, Public Health and Safety, Issues and Recommendations”. The report focused on five (5) key areas: (1) Barriers to Researching Cannabis, (2) Impacts of Increased Cannabis Potency, (3) Cannabis Use on the Developing Brain, (4) Unregulated Products and (5) Cannabis Impaired Driving. The National Marijuana […]
In the February 2, 2021 edition of Jama Network Open, a study titled, “Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older, A Systematic Review and Metaregression Analysis” (Velayudhan et.al.) was released. While there are numerous studies that examine youth / young adults, marijuana use and adverse mental health issues, this study […]
March 2021 – The Drug Enforcement Administration (DEA) has just released their National Drug Threat Assessment of drugs in American for 2020. This unclassified publication is based in law enforcement intelligence and data from the public health sector. It provides a broad overview of the drugs (illicit and legal) in American society and their connections […]
In 2017, Colorado passed House Bill 17-1315 which requires the Colorado Department of Public Safety to annually produce a report regarding data associated with impaired driving in the state. One of the requirements was to include data not only for alcohol, but on other drugs to include marijuana. As with all longitudinal data, the more […]
Currently, there is scant policy or guidance when it comes to either smoking or vaping cannabis. Similarly there is no uniform policy as to the potency levels of products available in today’s public market; nor a complete understanding how the two administration methods (smoking v. vaping) can affect the user. The 2018 study, “Acute Effects […]
Date: January 22, 2021 The December 1st, 2020 edition of JAMA (Vol. 324, No. 21) released the results of a study into impaired driving from the Netherlands titled, “Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance” by T. Arkell (et.al.). The near year-long study examined the effects of vaporized cannabis products on safe driving performance. […]
